Last reviewed · How we verify
PCEA: Patient Controlled Epidural Analgesia
PCEA: Patient Controlled Epidural Analgesia is a Small molecule drug developed by Hospital del Rio Hortega. It is currently in Phase 3 development for Pain relief for patients undergoing medical procedures or experiencing chronic pain.
PCEA works by delivering a controlled amount of analgesic medication directly to the epidural space, providing pain relief for patients.
PCEA works by delivering a controlled amount of analgesic medication directly to the epidural space, providing pain relief for patients. Used for Pain relief for patients undergoing medical procedures or experiencing chronic pain.
At a glance
| Generic name | PCEA: Patient Controlled Epidural Analgesia |
|---|---|
| Sponsor | Hospital del Rio Hortega |
| Modality | Small molecule |
| Therapeutic area | Pain Management |
| Phase | Phase 3 |
Mechanism of action
This is achieved through the use of a pump that allows patients to self-administer a predetermined dose of medication, typically a local anesthetic or opioid, into the epidural space surrounding the spinal cord. This targeted delivery helps to reduce pain and discomfort associated with various medical procedures or conditions.
Approved indications
- Pain relief for patients undergoing medical procedures or experiencing chronic pain
Common side effects
- Nausea
- Dizziness
- Headache
- Itching
- Hypotension
- Respiratory depression
Key clinical trials
- Continuous Epidural With Dexmedetomidine Adjuvant in Gynecologic Laparotomy (PHASE4)
- Genicular Nerve Block Added to Femoral Nerve Block for Analgesia After Total Knee Arthroplasty (NA)
- PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies (NA)
- Comparing PIEB and CEI for Labor Pain Relief (NA)
- Effect of the PIEB Versus CEI on the Quality of Postoperative Recovery in Patients Undergoing VATS Lobectomy (NA)
- Influence of Analgesic Technique on Post Operative Rehabilitation After Median Laparotomy (NA)
- Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery (PHASE4)
- Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PCEA: Patient Controlled Epidural Analgesia CI brief — competitive landscape report
- PCEA: Patient Controlled Epidural Analgesia updates RSS · CI watch RSS
- Hospital del Rio Hortega portfolio CI
Frequently asked questions about PCEA: Patient Controlled Epidural Analgesia
What is PCEA: Patient Controlled Epidural Analgesia?
How does PCEA: Patient Controlled Epidural Analgesia work?
What is PCEA: Patient Controlled Epidural Analgesia used for?
Who makes PCEA: Patient Controlled Epidural Analgesia?
What development phase is PCEA: Patient Controlled Epidural Analgesia in?
What are the side effects of PCEA: Patient Controlled Epidural Analgesia?
Related
- Manufacturer: Hospital del Rio Hortega — full pipeline
- Therapeutic area: All drugs in Pain Management
- Indication: Drugs for Pain relief for patients undergoing medical procedures or experiencing chronic pain
- Compare: PCEA: Patient Controlled Epidural Analgesia vs similar drugs
- Pricing: PCEA: Patient Controlled Epidural Analgesia cost, discount & access